New Analyst Forecast: $EMR Given $125.0 Price Target

We just received data on a new analyst forecast for $EMR. Julian Mitchell from Barclays set a price target of 125.0 for EMR.

To track analyst ratings and price targets for $EMR, check out Quiver Quantitative's $EMR forecast page.

$EMR Price Targets

Multiple analysts have issued price targets for $EMR recently. We have seen 9 analysts offer price targets for $EMR in the last 6 months, with a median target of $133.0.

Here are some recent targets:

• Julian Mitchell from Barclays set a target price of $125.0 on 07/09/2025
• Andrew Obin from B of A Securities set a target price of $155.0 on 07/02/2025
• Ken Newman from Keybanc set a target price of $155.0 on 07/01/2025
• Joseph O'Dea from Wells Fargo set a target price of $150.0 on 07/01/2025
• Andrew Kaplowitz from Citigroup set a target price of $146.0 on 06/04/2025
• Stephen Tusa from JP Morgan set a target price of $133.0 on 05/16/2025
• Michael Halloran from Baird set a target price of $130.0 on 05/08/2025

$EMR Congressional Stock Trading

Members of Congress have traded $EMR stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $EMR stock by members of Congress over the last 6 months:

• REPRESENTATIVE BRUCE WESTERMAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 03/03 and 1 sale worth up to $15,000 on 04/21.
• REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 02/25 and 1 sale worth up to $15,000 on 04/08.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$EMR Insider Trading Activity

$EMR insiders have traded $EMR stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $EMR stock by insiders over the last 6 months:

• MICHAEL H. TRAIN (SVP & Chief Sustain Officer) sold 28,305 shares for an estimated $3,380,749
• SURENDRALAL LANCA KARSANBHAI (President & CEO) sold 16,698 shares for an estimated $1,892,384
• MARK A BLINN has made 0 purchases and 2 sales selling 1,887 shares for an estimated $237,205.
• MATTHEW S LEVATICH sold 1,867 shares for an estimated $233,472

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$EMR Hedge Fund Activity

We have seen 843 institutional investors add shares of $EMR stock to their portfolio, and 952 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN added 2,164,069 shares (+71.6%) to their portfolio in Q1 2025, for an estimated $237,268,525
• PACER ADVISORS, INC. added 2,138,397 shares (+4583.7%) to their portfolio in Q1 2025, for an estimated $234,453,847
• VAN ECK ASSOCIATES CORP removed 1,960,317 shares (-97.6%) from their portfolio in Q1 2025, for an estimated $214,929,155
• ALLIANCEBERNSTEIN L.P. added 1,693,999 shares (+218.7%) to their portfolio in Q1 2025, for an estimated $185,730,050
• FISHER ASSET MANAGEMENT, LLC added 1,595,914 shares (+78.4%) to their portfolio in Q1 2025, for an estimated $174,976,010
• BLACKROCK, INC. added 1,555,156 shares (+4.3%) to their portfolio in Q1 2025, for an estimated $170,507,303
• MASSACHUSETTS FINANCIAL SERVICES CO /MA/ added 1,333,839 shares (+210.8%) to their portfolio in Q1 2025, for an estimated $146,242,107

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.